BSEQualitek Labs LtdLowNeutral
Announced Wed, 20 May · 20:30 IST

In terms of Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of Qualitek Labs Limited ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹400.00
prior close
₹450.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.4-6.6-2.9-4.2+2.0+2.5+4.3+5.0+4.5+2.0+3.0+0.0
Up moveDown movePending
AI summary

Qualitek Labs Limited reported strong audited financial results for FY2026 ending March 31. Consolidated revenue grew 77% to ₹12,451.81 Lakh from ₹7,022.69 Lakh, while standalone revenue increased 47% to ₹6,762.45 Lakh. Consolidated net profit rose 90% to ₹1,460.15 Lakh (standalone: ₹796.44 Lakh, up 51%). EPS improved to ₹13.38 consolidated and ₹7.30 standalone. The company completed several acquisitions during the year including making Interstellar Testing Centre a wholly-owned subsidiary, acquiring a food testing lab in Mumbai for ₹882 Lakh, and 74% stake in LabOps Global. Statutory auditors issued an unmodified (clean) audit opinion on both standalone and consolidated results.

Likely market impact

Strong double-digit growth in revenue and profit signals healthy operational performance. The clean audit opinion removes any concerns about financial reporting quality. Multiple acquisitions and NABL accreditation for a new lab indicate ongoing expansion strategy, though increased borrowings should be monitored.